SeaCrest Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SeaCrest Wealth Management's NVS Position: Q3 2026 in Review
SeaCrest Wealth Management sold out of Novartis (NVS) in Q3 2026, closing a stake of 1,357 shares — an estimated $213K sold.
SeaCrest Wealth Management first reported a position in NVS in Q4 2017 and held it in 17 quarters. The position peaked at $284K in Q3 2023. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- SeaCrest Wealth Management reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- SeaCrest Wealth Management sold 1,357 Novartis shares in Q3 2026, an estimated $213K.
- SeaCrest Wealth Management first reported a position in Novartis in Q4 2017 and held it in 17 quarters.
- SeaCrest Wealth Management's Novartis position peaked at $284K in Q3 2023.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on SeaCrest Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.